766P - Prognostic effect of systemic immune-inflammation index (SII) in 987 patients with advanced/metastatic urinary tract carcinoma (mUTC) treated with atezolizumab in the real-world global SAUL study

Research output: Contribution to conferencePosterAcademic

Original languageEnglish
Publication statusPublished - 17 Sep 2020
EventEuorpean Society for medical oncology : ESMO annual meeting 2020 -
Duration: 14 Sep 2020 → …


ConferenceEuorpean Society for medical oncology
Abbreviated titleESMO
Period14/09/2020 → …

Cite this